RSS Newsfeeds

See all RSS Newsfeeds

Apr 27, 2017 3:40 PM ET

Archived: -US Procedure Numbers for Dialysis Devices 2017 – Limited by Falling Prices & Resistance to Transition to Home Dialysis

iCrowdNewswire - Apr 27, 2017

M2 PRESSWIRE-April 27, 2017-US Procedure Numbers for Dialysis Devices 2017 – Limited by Falling Prices & Resistance to Transition to Home Dialysis


Dublin – Research and Markets has announced the addition of the “US Procedure Numbers for Dialysis Devices 2017 – MedPro” report to their offering.

The total market comprised the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, hemodialysis bloodlines, AV fistula needles, AV grafts, AV declotting devices, guidewires, introducer sheaths and water treatment systems. The AV fistula and AV fistula needle market will be the fastest growing market over the forecast period as the Fistula First Breakthrough Initiative gains more traction and more medical professionals recommend AV fistula’s at hemodialysis initiation for improved results and increased patient safety.

The dialysis market, contrary to industry efforts, has been slow to transition away from in-center hemodialysis treatments. The reassurance and safety of having trained professionals available is a strong incentive to follow an in-center treatment plan. Additionally, despite the increasing number of patients requiring dialysis, many are not eligible for home treatment options.

The dialysis market is being limited by falling prices and the resistance to transition to home dialysis. While all types of dialysis are still growing, the market share increase per new patient is the lowest for in-center hemodialysis. As more patients shift to alternative methods of treatment, this will help fuel market growth.

Companies Mentioned

– Fresenius
– Baxter
– Rockwell Medical
– Medivators
– MarCor
– Medisystems
– B. Braun
– Nipro Medical
– Asahi Kasei Medical
– Medcomp
– Medtronic
– Teleflex Medical
– AmeriWater
– Merit Medical Systems
– C.R. Bard
– Edwards Lifesciences
– NxStage Medical
– AngioDynamics
– Tarumo
– W.L. Gore
– Cook Medical
– Kawasumi Laboratories
– Lemaitre Vascular Inc.
– Cordis
– Boston Scientific
– Abbott
– Argon Medical
– Atrium
– Artegraft
– Angelini Pharma Inc.

For more information about this report visit http://www.researchandmarkets.com/research/wnmnc8/us_procedure

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Dialysis (http://www.researchandmarkets.com/categories.asp?cat_id=244&campaign_id=wnmnc8)

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to info@m2.com)).

Via iCrowdNewswire
Tags: , Wire, M2 Presswire
View Related News >